SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-004673
Filing Date
2022-02-11
Accepted
2022-02-11 06:31:21
Documents
71
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q tyme-10q_20211231.htm   iXBRL 10-Q 2138664
2 EX-31.1 tyme-ex311_8.htm EX-31.1 12565
3 EX-31.2 tyme-ex312_9.htm EX-31.2 12509
4 EX-32.1 tyme-ex321_6.htm EX-32.1 8357
  Complete submission text file 0001564590-22-004673.txt   8649716

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA tyme-20211231.xsd EX-101.SCH 60348
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tyme-20211231_cal.xml EX-101.CAL 47220
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tyme-20211231_def.xml EX-101.DEF 208490
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE tyme-20211231_lab.xml EX-101.LAB 420575
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tyme-20211231_pre.xml EX-101.PRE 345773
65 EXTRACTED XBRL INSTANCE DOCUMENT tyme-10q_20211231_htm.xml XML 1804193
Mailing Address 1 PLUCKEMIN WAY - SUITE 103 BEDMINSTER NJ 07921
Business Address 1 PLUCKEMIN WAY - SUITE 103 BEDMINSTER NJ 07921 212-461-2315
TYME TECHNOLOGIES, INC. (Filer) CIK: 0001537917 (see all company filings)

IRS No.: 453864597 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-38169 | Film No.: 22616586
SIC: 2834 Pharmaceutical Preparations